Junshi Biosciences Announces 2023 Full Year Financial Results and Provides Corporate Updates
- Corax Consultants LLC
- 29. März 2024
- 1 Min. Lesezeit
SHANGHAI, China, March 29, 2024 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial results for the full year of 2023 and provided corporate updates. Junshi Biosciences Announces 2023 Full Year Financial Results and Provides Corporate Updates
Kommentare